University of California San Francisco
San Francisco, California, United States
Purpose
to leverage HIV therapeutic vaccine trial to identify features of vaccine-elicited CD8+ T cells that may also promote prevention of HIV acquisition and/or HIV control after stopping antiretroviral therapy
Division
Global Health
Date
November 2022
Region Served
AFRICA
Committed amount
$1,496,489
Grant topic
Create Novel Technology Platform Capabilities, HIV
Duration (months)
48
Grantee location
San Francisco, California, United States
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.